[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100565271":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":29,"responsibleParty":46,"collaborators":10,"id":48,"slug":10,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":10,"eligibilityCriteria":52,"healthyVolunteers":49,"sex":53,"minAge":54,"maxAge":10,"enrollmentInfo":55,"targetDuration":10,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":10,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational",null,"Patients undergo blood sample collection and have their medical records reviewed on study.",[13],"Other: Non-Interventional Study",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Non-Interventional Study","Non-interventional study",[9],[20],{"name":21,"affiliation":5,"role":22},"Nadine Norton, PhD","PRINCIPAL_INVESTIGATOR",[24],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Clinical Trials Referral Office","CONTACT","855-776-0015","mayocliniccancerstudies@mayo.edu",[30],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Mayo Clinic in Florida","RECRUITING","Jacksonville","Florida","32224-9980","United States",{"type":38,"coordinates":39},"Point",[40,41],-81.65565,30.33218,{"lat":41,"lon":40},[44,45],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},{"name":21,"role":22,"phone":10,"phoneExt":10,"email":10},{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100565271",false,"NCT06640010","Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events","Inclusion Criteria:\n\n* Any patient \\>= 18 years of age\n* Previously treated, planned or currently receiving any potentially toxic cancer therapy including but not limited to chemotherapy, targeted and immunotherapies\n\nExclusion Criteria:\n\n* Inability on the part of the patient to understand the informed consent or be compliant with the protocol","ALL","18 Years",{"count":56,"type":57},30,"ESTIMATED","OBSERVATIONAL","This study is being done to find out if patient blood samples can be used to perform individualized modeling of cancer therapy-related side effects.",[61,62],"Hematopoietic and Lymphatic System Neoplasm","Malignant Solid Neoplasm","2026-06-18",{"date":65,"type":66},"2026-06-23","ACTUAL",{"date":68,"type":66},"2025-02-12",{"date":70,"type":57},"2027-12-15",{"name":5,"class":6},1]